Carbon nanotubes in the diagnosis and treatment of malignant melanoma.
The potential role of carbon nanotubes (CNTs) in the diagnosis and treatment of malignant melanoma (MM) is still an emerging area of research. To date, there is strong evidence for the efficiency of CNTs in this therapeutic area, despite their unique physical, mechanical and biological properties. In this review, the application of CNTs in cancer diagnostics and treatment is reviewed, and consideration is given to the toxicity issues associated with their use.
UCL Centre for Nanotechnology and Regenerative Medicine, Division of Surgery & Interventional Sciences, University College London, London, UK.
Naghmeh
N
Naderi
Seyed Y
SY
Madani
Elaine
E
Ferguson
Afshin
A
Mosahebi
Alexander M
AM
Seifalian
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D016503:Drug Delivery Systems; D006801:Humans; D008545:Melanoma / Q000175:diagnosis* / Q000188:drug therapy*; D037742:Nanotubes, Carbon; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000188:drug therapy*
D000970:Antineoplastic Agents; D037742:Nanotubes, Carbon